Related Experiment Video
Updated: May 15, 2025

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING
Ping Lai1, Lei Liu2, Nicolò Bancaro2
1Institute of Oncology Research (IOR), Bellinzona 6500, Switzerland; Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne 1011, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano 6962, Switzerland.
Abstract:
Mitochondrial dysfunction is a hallmark of cellular senescence. Here, we investigated whether senescent cells release mitochondrial (mt)DNA into the extracellular space and its impact on innate immunity. We found that both primary senescent cells and tumor cells undergoing therapy-induced senescence actively released mtDNA into the extracellular environment. mtDNA released by senescent cells was packaged within extracellular vesicles and selectively transferred to polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in the tumor microenvironment. Upon uptake, extracellular mtDNA enhanced the immunosuppressive activity of PMN-MDSCs via cGAS-STING-NF-κB signaling, thereby promoting tumor progression. While STING activation directly induced NF-κB signaling, it also activated PKR-like endoplasmic reticulum kinase (PERK), which further amplified NF-κB activity, in PMN-MDSCs. mtDNA release from senescent cells was mediated by voltage-dependent anion channels (VDACs), and pharmacological inhibition of VDAC reduced extracellular mtDNA levels, reversed PMN-MDSC-driven immunosuppression, and enhanced chemotherapy efficacy in prostate cancer mouse models. These findings suggest that targeting mtDNA release could reprogram the immunosuppressive tumor microenvironment, improving therapeutic outcomes for chemotherapy-treated patients.
Insights
Senescent cells release mitochondrial DNA (mtDNA) packaged in vesicles, which enhances immunosuppressive myeloid cells in tumors. Inhibiting mtDNA release via VDAC channels improved chemotherapy efficacy in prostate cancer models.
Area of Science:
- Immunology
- Cellular Biology
- Cancer Research
Background:
- Cellular senescence is linked to mitochondrial dysfunction.
- The role of extracellular mitochondrial DNA (mtDNA) in innate immunity and tumor progression is not fully understood.
Purpose of the Study:
- To investigate the release of mtDNA from senescent cells.
- To determine the impact of extracellular mtDNA on the tumor microenvironment and innate immunity.
- To explore the therapeutic potential of targeting mtDNA release.
Main Methods:
- Primary and therapy-induced senescent cells were analyzed for mtDNA release.
- Extracellular vesicles containing mtDNA were characterized.
- The transfer of mtDNA to polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) was studied.
- cGAS-STING-NF-κB and PERK signaling pathways were investigated.
- Voltage-dependent anion channels (VDACs) were targeted pharmacologically in prostate cancer mouse models.
Main Results:
- Senescent cells actively release mtDNA into the extracellular environment, packaged within extracellular vesicles.
- Extracellular mtDNA is transferred to PMN-MDSCs, enhancing their immunosuppressive activity via cGAS-STING-NF-κB and PERK signaling.
- Pharmacological inhibition of VDAC reduced extracellular mtDNA, reversed PMN-MDSC immunosuppression, and improved chemotherapy efficacy in preclinical models.
Conclusions:
- Extracellular mtDNA released by senescent cells promotes tumor progression by enhancing PMN-MDSC immunosuppression.
- Targeting VDAC-mediated mtDNA release offers a potential strategy to reprogram the tumor microenvironment.
- Inhibiting mtDNA release may improve therapeutic outcomes for cancer patients undergoing chemotherapy.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Replicative Cell Senescence

